Ryan Marten, MD
![1]()
News
Rivaroxaban versus heparin at preventing recurrent, cancer-related VTE
April 12, 2019
Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous thromboembolism (VTE)?
